158 related articles for article (PubMed ID: 36410226)
21. [Diffuse midline glioma].
Saito R
No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084
[TBL] [Abstract][Full Text] [Related]
22. Brainstem glioma: a review.
Grimm SA; Chamberlain MC
Curr Neurol Neurosci Rep; 2013 May; 13(5):346. PubMed ID: 23512689
[TBL] [Abstract][Full Text] [Related]
23. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.
Hoffman LM; Veldhuijzen van Zanten SEM; Colditz N; Baugh J; Chaney B; Hoffmann M; Lane A; Fuller C; Miles L; Hawkins C; Bartels U; Bouffet E; Goldman S; Leary S; Foreman NK; Packer R; Warren KE; Broniscer A; Kieran MW; Minturn J; Comito M; Broxson E; Shih CS; Khatua S; Chintagumpala M; Carret AS; Escorza NY; Hassall T; Ziegler DS; Gottardo N; Dholaria H; Doughman R; Benesch M; Drissi R; Nazarian J; Jabado N; Boddaert N; Varlet P; Giraud G; Castel D; Puget S; Jones C; Hulleman E; Modena P; Giagnacovo M; Antonelli M; Pietsch T; Gielen GH; Jones DTW; Sturm D; Pfister SM; Gerber NU; Grotzer MA; Pfaff E; von Bueren AO; Hargrave D; Solanki GA; Jadrijevic Cvrlje F; Kaspers GJL; Vandertop WP; Grill J; Bailey S; Biassoni V; Massimino M; Calmon R; Sanchez E; Bison B; Warmuth-Metz M; Leach J; Jones B; van Vuurden DG; Kramm CM; Fouladi M
J Clin Oncol; 2018 Jul; 36(19):1963-1972. PubMed ID: 29746225
[TBL] [Abstract][Full Text] [Related]
24. End-of-life care of children with diffuse intrinsic pontine glioma.
Hasan F; Weingarten K; Rapoport A; Bouffet E; Bartels U
J Neurooncol; 2018 May; 138(1):147-153. PubMed ID: 29397521
[TBL] [Abstract][Full Text] [Related]
25. Pediatric diffuse intrinsic pontine glioma: where do we stand?
Rashed WM; Maher E; Adel M; Saber O; Zaghloul MS
Cancer Metastasis Rev; 2019 Dec; 38(4):759-770. PubMed ID: 31802357
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.
Lober RM; Cho YJ; Tang Y; Barnes PD; Edwards MS; Vogel H; Fisher PG; Monje M; Yeom KW
J Neurooncol; 2014 Mar; 117(1):175-82. PubMed ID: 24522717
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy approaches for the treatment of diffuse midline gliomas.
Bernstock JD; Hoffman SE; Kappel AD; Valdes PA; Essayed W; Klinger NV; Kang KD; Totsch SK; Olsen HE; Schlappi CW; Filipski K; Gessler FA; Baird L; Filbin MG; Hashizume R; Becher OJ; Friedman GK
Oncoimmunology; 2022; 11(1):2124058. PubMed ID: 36185807
[TBL] [Abstract][Full Text] [Related]
28. Decreased natural killer cells in diffuse intrinsic pontine glioma patients.
Zhang L; Yu H; Xue Y; Liu Y
Childs Nerv Syst; 2020 Jul; 36(7):1345-1346. PubMed ID: 32418048
[TBL] [Abstract][Full Text] [Related]
29. Incidental diagnosis of diffuse intrinsic pontine glioma in children.
Wright KD; Sabin ND; Cheuk D; McNall-Knapp R; Shurtleff SA; Gajjar A; Broniscer A
Pediatr Blood Cancer; 2015 Jun; 62(6):1081-3. PubMed ID: 25598012
[TBL] [Abstract][Full Text] [Related]
30. Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience.
Mueller T; Laternser S; Guerreiro Stücklin AS; Gerber NU; Mourabit S; Rizo M; Rushing EJ; Kottke R; Grotzer M; Krayenbühl N; Nazarian J; Mueller S
Eur J Cancer; 2023 Jan; 178():171-179. PubMed ID: 36455411
[TBL] [Abstract][Full Text] [Related]
31. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
Hoffman LM; DeWire M; Ryall S; Buczkowicz P; Leach J; Miles L; Ramani A; Brudno M; Kumar SS; Drissi R; Dexheimer P; Salloum R; Chow L; Hummel T; Stevenson C; Lu QR; Jones B; Witte D; Aronow B; Hawkins CE; Fouladi M
Acta Neuropathol Commun; 2016 Jan; 4():1. PubMed ID: 26727948
[TBL] [Abstract][Full Text] [Related]
32. The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies.
Persson ML; Douglas AM; Alvaro F; Faridi P; Larsen MR; Alonso MM; Vitanza NA; Dun MD
Neuro Oncol; 2022 Sep; 24(9):1408-1422. PubMed ID: 35481923
[TBL] [Abstract][Full Text] [Related]
33. Development of a clinical scale for assessment of patients with diffuse intrinsic pontine glioma (DIPG) receiving experimental therapy: the PONScore.
Hollingworth MA; Zacharoulis S
J Neurooncol; 2020 Sep; 149(2):263-272. PubMed ID: 32902768
[TBL] [Abstract][Full Text] [Related]
34. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
35. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
[TBL] [Abstract][Full Text] [Related]
36. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.
Fangusaro J
J Child Neurol; 2009 Nov; 24(11):1409-17. PubMed ID: 19638636
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic transventricular biopsy in brainstem diffuse midline glioma: how I do it.
La Corte E; Babini M; Bortoluzzi G; Zucchelli M
Acta Neurochir (Wien); 2023 Apr; 165(4):1099-1103. PubMed ID: 36481874
[TBL] [Abstract][Full Text] [Related]
38. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
Kilburn LB; Kocak M; Baxter P; Poussaint TY; Paulino AC; McIntyre C; Lemenuel-Diot A; Lopez-Diaz C; Kun L; Chintagumpala M; Su JM; Broniscer A; Baker JN; Hwang EI; Fouladi M; Boyett JM; Blaney SM
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29090526
[TBL] [Abstract][Full Text] [Related]
39. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.
Veldhuijzen van Zanten SE; van Meerwijk CL; Jansen MH; Twisk JW; Anderson AK; Coombes L; Breen M; Hargrave OJ; Hemsley J; Craig F; Cruz O; Kaspers GJ; van Vuurden DG; Hargrave DR;
Neuro Oncol; 2016 Apr; 18(4):582-8. PubMed ID: 26459800
[TBL] [Abstract][Full Text] [Related]
40. Diffuse intrinsic pontine glioma in children and adolescents: a single-center experience.
Vallero SG; Bertin D; Basso ME; Pittana LS; Mussano A; Fagioli F
Childs Nerv Syst; 2014 Jun; 30(6):1061-6. PubMed ID: 24420674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]